Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026 [Yahoo! Finance]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
Q4 sales growth of 13.3% at CER and business earnings per share (EPS) of €1.53 Pharma launches increased sales by 49.4%, reaching €1.1 billion, primarily driven by Ayvakit and ALTUVIIIO Dupixent sales increased by 32.2% to €4.2 billion, a strong end to the year Vaccines sales decreased by 2.5% to €2.0 billion, with influenza performing better than anticipated Research and Development expenses reached €2.3 billion, up by 6.6% Selling, general and administrative expenses reached €2.7 billion, up by 9.6%, supporting launches Business EPS was €1.53, up by 26.7% at CER; 16.8% at actual exchange rates, delivering profitable growth; IFRS EPS -€0.66 Pipeline progress Ten regulatory approvals across immunology, rare diseases, and other Positive phase 3 readouts: amlitelimab program in AD (COAST 2, SHORE) and Dupixent in AFRS Tolebrutinib in PPMS did not meet the primary endpoint Four regulatory submission acceptances, five phase 3 study starts, three regulatory designati
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax gains on disclosure another bidder interested after deal announced [Seeking Alpha]Seeking Alpha
- Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Lightning Round: Buy some Talen Energy here, says Jim Cramer [CNBC]CNBC
- Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTFGlobeNewswire
DVAX
Earnings
- 11/5/25 - Beat
DVAX
Sec Filings
- 1/30/26 - Form SC
- 1/30/26 - Form SC
- 1/28/26 - Form SC
- DVAX's page on the SEC website